NYSE: OPY

Oppenheimer (OPY) Stock Analysis & Forecast

Oct 12 close

$111.42−2.52 (−2.2%)

Gekko Brief

AI summaryOct 12 close

Oppenheimer's own research desk made headlines this week rather than the firm's core brokerage business, with an analyst note arguing Viking Therapeutics shares could reach $120 on the strength of its VK2735 drug candidate for weight loss and type 2 diabetes. The piece describes varying sales projections and highlights the therapy's potential to gain market share, reflecting both promise and uncertainty around the compound rather than news specific to Oppenheimer's own operations.

OPY closed at $111.42, down 2.2% on the day, with the stock sitting between its 50-day average of $117.38 and its 200-day average of $100.62. Shorter-term returns show a 9.6% decline over one month against a 61.8% gain over the past year. The GekkoIndex reads 63.4, placing the stock in the Accumulation zone and up 10.1 over the past five sessions, while price stands 16.4% above Gekko Fair Value of $95.72.

Earnings are set for 30 October, before the open, 17 days out and inside a typical 20-trading-day holding period; the prior quarter posted EPS of $3.98, beating estimate, with a 2.2% reaction and an average absolute move of 8% historically. No insider, Congress, or unusual options activity appears in the recent windows. Seasonally, the next 20 trading days have averaged a 14.4% gain over five years, rising in all five. Consensus analyst target sits at $37.

Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.

Oppenheimer price vs fair value

$111.42$95.72Oct ’25Apr ’26Oct ’26
Close $111.42200-day averageGekko Fair Value $95.72

Oppenheimer quick facts

Market cap
$1.18B
P/E ratio
12.9
Forward P/E
10.8
EPS, TTM
$9.01
Revenue, TTM
$1.72B
Profit margin
6%
Dividend yield
0.64%
Beta
1.10
Volume
100,425 avg 123,994
1-year return
+61.8%
Typical daily move
±3.7%
Typical 20-day move
±5.7%
50-day average
$117.38
200-day average
$100.62
Next earnings
Oct 30 before open
Shares outstanding
10.61M
52-week range
$63.81$125.88

Oppenheimer swing-trade checklist

Oppenheimer scores 2 supportive, 1 mixed and 2 headwinds across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

2 supportive1 mixed2 headwinds

  • Trendmixed

    Averages disagree

    Close $111.42 sits between the 50-day ($117.38) and 200-day ($100.62) averages, or the averages disagree.

    See the chart
  • GekkoIndexsupportive

    63.4, Accumulation

    Reading 63.4 is in the Accumulation zone.

    See the GekkoIndex
  • Fair valueheadwind

    16.4% above

    Price is 16.4% above Gekko Fair Value (more than 5% above).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings riskheadwind

    Reports in 18 days

    Reports on Oct 30, 2026, 18 days away — inside a typical 20-trading-day hold.

    See earnings
  • Seasonalitysupportive

    +14.4% on average

    From this point in the calendar, the next 20 trading days averaged +14.4% over 5 years, rising in 5 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Oppenheimer stock chart and price history

Oppenheimer closed at $111.42 on Oct 12, 2026, +61.8% over the past year, inside a 52-week range of $63.81 to $125.88.

Close50-day average200-day averageVolume
Oppenheimer share price, past year, with 50-day and 200-day moving averages and volume$80$100$120NovDecJan 2026FebMarAprMayJunJulAugSepOct111.42

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
−9.6%
3 months
−5.8%
6 months
+3.2%
1 year
+61.8%
The full OPY chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open OPY in Gekko

Follow Oppenheimer through every session

Put OPY on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track OPY in GekkoFree for 7 days. No credit card required.

About Oppenheimer

Oppenheimer operates as a middle-market investment bank and full-service broker-dealer, with activity spanning the Americas, Europe, the Middle East, and Asia. It works with wealthy individuals, corporate leaders, private and public organizations, institutions, government entities, financial sponsors, and other investors, and is known for the breadth of brokerage and advisory work it carries out for these groups.

Its business runs across several lines. The brokerage side handles listed and over-the-counter equities and debt, money market products, options, futures, municipal bonds, funds, and unit investment trusts, alongside wealth planning, advisory guidance, and margin lending. A separate asset management arm builds portfolios through managed accounts, discretionary programs, alternative investments, and fixed income strategies. For corporate and institutional clients, Oppenheimer arranges capital raising, mergers and acquisitions support, and equity and debt offerings, plus institutional sales, trading, and research across equities, derivatives, convertibles, and fixed income, along with public finance, securities lending, underwriting, market-making, and trust services.

The company has its roots in New York, tracing back to 1881, and its shares are listed on the NYSE under the ticker OPY.

Listed
NYSE
Sector
Finance
Industry
Investment banks/Brokers
Website
oppenheimer.com

Oppenheimer GekkoIndex: the smart money zone

Oppenheimer’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 63.4, in the Accumulation zone, up 10.1 points over five sessions.

010063.4Accumulation

Up 10.1 points over five sessions, from the Neutral zone.

Reading for Oct 12, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying8Too few readings yet
Accumulation (current zone)159+0.7%+1.7%+5.2%+13.7%
Neutral442+1.2%+2.4%+4.3%+9.0%
Distribution68−0.4%−1.3%−2.1%+5.9%
Selling5Too few readings yet

Average OPY share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.2% over 20 days. Past behaviour doesn’t guarantee future results.

Accumulation zone: Institutional interest building. About the five zones →

See every daily GekkoIndex reading plotted over the OPY price, zone by zone.Track OPY in Gekko

Is Oppenheimer stock overvalued? Gekko Fair Value

Oppenheimer trades 16.4% above Gekko Fair Value of $95.72, so the shares are overvalued on Gekko’s estimate.

Gekko’s own estimate of what Oppenheimer shares are worth, recalculated every trading day.

$95.72

Gekko Fair Value, Oct 10, 2026

16.4% Overvalued

At the end of Aug 2026 the price was 87.0% above the estimate.

Gekko Fair ValueShare price, month end
$96$114Aug 2026SepOct 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open OPY in Gekko

Oppenheimer insider and Congress trading

No open-market insider purchases were filed for Oppenheimer, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for OPY in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every OPY insider filing, plotted on the chart in Gekko.Open OPY in Gekko

Congress trades last 90 days

No trades in OPY were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for OPY, plotted on the chart in Gekko.Open OPY in Gekko

Buybacks

Oppenheimer has been buying back its own shares.

Bought back, quarter ended Dec 31, 2025
$2.31M
As a share of market cap
0.20%

From company filings.

Oppenheimer earnings: next date and track record

Oppenheimer reports on Oct 30, 2026, before the open (18 days away), and beat the EPS estimate in 1 of its last 1 report.

1 of 1reports beat the EPS estimate
±8%average move across the report
3 of 8reports followed by a gain

Share-price move across each report

+18.8%Oct ’24−6.0%Jan ’25−1.6%Apr ’25−1.7%Aug ’25−3.2%Oct ’25+16.9%Jan ’26−13.9%May ’26+2.2%Jul ’26
ReportedEPSSurpriseRevenueSurpriseMove
Jul 31, 2026$3.98—$454.9M—+2.2%
May 1, 2026$4.21—$445.1M—−13.9%
Jan 30, 2026$6.51—$472.6M—+16.9%
Oct 31, 2025$1.90
est $0.00
—$424.4M—−3.2%
Aug 1, 2025$1.91—$373.2M—−1.7%
Apr 25, 2025$2.72—$367.8M—−1.6%
Jan 31, 2025$0.92—$375.4M—−6.0%
Oct 25, 2024$2.17—$373.4M—+18.8%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Oppenheimer stock forecast and analyst price targets

Analysts’ average 12-month price target for Oppenheimer is $37.00, −66.8% from the last close.

$37.00consensus 12-month target, −66.8% from the last close
+5.2%average 20-day move after past Accumulation readings
+14.4%average move over the next 20 trading days in the last 5 years
±3.7%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Oppenheimer seasonality: the next 20 trading days

Over the next 20 trading days from Oct 10, Oppenheimer averaged +14.4% across the last 5 years, rising in 5 of them.

Next 20 trading days, by year

+6.4%2021+33.1%2022+1.9%2023+28.7%2024+1.9%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days+1.0%5 of 5
Next 10 trading days+0.8%3 of 5
Next 15 trading days+8.6%4 of 5
Next 20 trading days+14.4%5 of 5
Next 30 trading days+15.1%4 of 5

For scale, OPY’s typical 20-trading-day move in either direction is about 5.7%.

Oppenheimer market cap and key statistics

Oppenheimer’s market cap is $1.18B, with a P/E ratio of 12.9 and revenue of $1.72B over the last twelve months.

Valuation

Market cap
$1.18B
P/E ratio
12.9
Forward P/E
10.8
EPS, TTM
$9.01
Gekko Fair Value
$95.72

Trading

Volume
100,425
Avg volume, 20 days
123,994
52-week high
$125.88
52-week low
$63.81
Shares outstanding
10.61M

Financials

Revenue, TTM
$1.72B
Profit margin
6%
Return on equity
10.8%
Quarterly earnings growth, YoY
+24.6%

Risk and income

Beta
1.10
Typical daily move
±3.7%
Typical 20-day move
±5.7%
Dividend yield
0.64%

Oppenheimer stock news this week

1 headline about Oppenheimer from the past week, newest first, each linking to the publisher.

Oppenheimer peers

Oppenheimer’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
GSGoldman Sachs−0.5%Accumulation12.8% below
SCHWCharles Schwab0.0%Accumulation13.6% below
IBKRInteractive Brokers−0.4%Accumulation8.8% below
CMECME−1.6%Neutral0.5% below
HOODRobinhood Markets+0.5%Accumulation7.5% below
BNYBank of New York Mellon−0.1%Accumulation10.2% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

Oppenheimer stock FAQ

What is Oppenheimer’s market cap?

Oppenheimer’s market cap is $1.18B at the Oct 12, 2026 close of $111.42, with 10.61M shares outstanding. The shares trade on a P/E ratio of 12.9.

What is the Oppenheimer stock forecast?

The consensus analyst 12-month price target for Oppenheimer is $37.00, −66.8% from the last close. Gekko doesn’t publish price predictions of its own.

Is Oppenheimer stock overvalued or undervalued?

On Gekko’s estimate Oppenheimer is overvalued: the Oct 12, 2026 close of $111.42 is 16.4% above Gekko Fair Value of $95.72. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Oppenheimer report earnings next?

Oppenheimer is expected to report on Oct 30, 2026, before the market opens (18 days away).

What is Oppenheimer’s 52-week high and low?

Oppenheimer’s 52-week high is $125.88 and its 52-week low is $63.81; it closed at $111.42 on Oct 12, 2026, +61.8% over the past year.

Is Oppenheimer stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (gekkoindex and seasonality), 1 as mixed (trend) and 2 as headwinds (fair value and earnings risk). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Oppenheimer the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,408 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.